Pharmaceutical Material Scientists are critical to the development and optimization of materials used in drug formulation and manufacturing. They focus on understanding the chemical and physical properties of excipients, polymers, and active pharmaceutical ingredients (APIs) to ensure drug formulations are stable, bioavailable, and effective. Their role involves selecting and designing materials that improve the solubility, stability, and controlled release of drugs, addressing challenges in the delivery of both traditional small-molecule drugs and newer biologics. By tailoring materials to specific drug delivery needs, pharmaceutical material scientists help enhance the overall therapeutic outcomes while minimizing potential side effects.
Formulation scientists, regulatory bodies, and production teams rely on pharmaceutical material scientists for their expertise throughout the drug development process—from early-stage research to large-scale manufacturing. Their contributions are essential in designing innovative drug delivery systems that target specific tissues, improve patient compliance, and ensure long-term drug efficacy. With the rise of complex treatments such as gene therapies, personalized medicines, and biologics, pharmaceutical material scientists play an increasingly important role in developing next-generation drug products. Their work ensures that new therapies are not only effective but also safe, sustainable, and cost-efficient, ultimately improving patient care and driving advancements in modern medicine. By optimizing the materials used in drug development, these specialists are at the forefront of creating novel and cutting-edge drug delivery technologies.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada